サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1678757

大腸スクリーニングの市場規模、シェア、動向分析レポート：タイプ別、製品別、最終用途別、地域別、セグメント別予測、2025年～2030年

Colon Screening Market Size, Share & Trends Analysis Report By Type (Test, Product), By Product (Colonoscopes, Sigmoidoscopes, CT Scanners, MRI), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
大腸スクリーニングの市場規模、シェア、動向分析レポート：タイプ別、製品別、最終用途別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年02月18日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

大腸スクリーニング市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の大腸スクリーニング市場規模は、2025～2030年にかけて4.39%のCAGRを記録し、2030年までに222億1,000万米ドルに達する見込みです。

大腸がんの有病率の増加、がん検診を奨励する政府のイニシアチブの増加、市場の継続的な技術進歩が市場成長を促進する主要要因です。2024年6月に発表されたCDCのデータによると、米国におけるIBDの有病率は240万人から310万人と推定されています。同様に、潰瘍性大腸炎の世界の有病率は2023年には500万人になると予想されています。

大腸スクリーニングにおける技術的に進歩した製品の開発が市場の成長に大きく寄与しています。これらの技術革新は、診断精度を高め、患者の快適性を向上させ、従来の処置に伴うリスクを最小化し、がんやポリープを含む大腸関連疾患の早期発見を可能にしました。例えば、2024年5月、FUJIFILMは2つの革新的な内視鏡イメージング技術CAD EYEとSCALE EYEを発表しました。CAD EYEは、大腸内視鏡検査におけるポリープや腺腫などの大腸粘膜病変の検出を強化するために設計されたAI搭載システムです。

加えて、大腸スクリーニングの認知度とアクセシビリティを高めるための世界中の民間と公的参入企業による取り組みの増加が、さまざまな地域にわたって市場をさらに牽引しています。例えば、2024年11月、グアム地域医療都市は、米国農務省農村開発プログラムからの助成金による先進的なカプセル内視鏡サービスを導入しました。この革新的で低侵襲な診断ソリューションは、グアムとその周辺地域の消化器医療における重要な進歩であり、患者の快適性を優先しながら医療技術を向上させています。このような開発は、先進的診断サービスへのアクセスを増加させ、市場開拓の原動力となります。

さらに、定期的なスクリーニングプログラムの普及は、がんや前がんポリープの発見に効果的な役割を担っています。さらに、AI支援検出を含む大腸内視鏡技術の進歩は、診断効率と患者の転帰を改善しています。例えば、2023年12月、メドトロニックは、内視鏡検査中に健康上の問題を自動的に検出するように設計されたプラグインソフトウェアの開発者であるCosmo Pharmaceuticalsとの人工知能連携を拡大しました。

同市場の主要企業は、より高い市場シェアを獲得するために、技術的進歩、新製品の発売、提携・協力に取り組んでいます。例えば、2022年2月、Medtronicは米国消化器内視鏡学会（ASGE）と提携し、米国の十分なサービスを受けていない地域で大腸がん検診のためのAI搭載大腸内視鏡技術を記載しています。

大腸スクリーニング市場レポートハイライト

  • タイプ別では、検査セグメントが2024年の市場で最大の収益シェアを占めました。簡単で非侵襲的なスクリーニング法に対する需要の高まりが、このセグメントの成長を促進しています。
  • 最終用途別では、結腸がんによる入院患者数の増加とがん検診導入の増加により、病院セグメントが2024年に市場で最大の収益シェアを占めました。
  • 北米は、多数の大手市場参入企業の存在と先進技術の採用率の高さにより、2024年の売上高シェア51.3％で世界市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 大腸スクリーニング市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 補助市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 大腸スクリーニング：市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析
  • 大腸スクリーニング市場の検査件数、2018～2024年
  • 大腸検査市場の製品別価格分析

第4章 大腸スクリーニング市場セグメント分析、タイプ別、2018～2030年

  • 定義と範囲
  • タイプ別市場シェア分析、2024年と2030年
  • セグメントダッシュボード
  • 世界の大腸スクリーニング市場、タイプ別、2018～2030年
  • 検査
    • 検査市場収益推定と予測、2018～2030年
    • 大腸内視鏡検査
    • カプセル内視鏡
    • 画像検査
    • その他
    • 最終用途、検査別
  • 製品
    • 製品市場収益推定と予測、2018～2030年
    • 大腸内視鏡
    • S状結腸鏡
    • CTスキャナ
    • 磁気共鳴画像（MRI）
    • 最終用途、製品別

第5章 大腸スクリーニング市場セグメント分析、地域別、2018～2030年

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 地域市場のスナップショット
  • 2024年と2030年の地域別大腸スクリーニング市場シェア
  • 北米
    • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 企業プロファイル
    • Olympus Corporation
    • PENTAX Medical（Hoya Corporation）
    • FUJIFILM Holdings Corporation
    • Medtronic
    • Ambu A/S
    • Baxter（Hillrom & Welch Allyn）
    • EndoFresh（Daichuan medical）
    • Bracco
    • Varay Laborix
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Colon Screening Market, By Type, 2018 - 2030 (USD Million)
  • Table 4 Global Colon Screening Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 North America Colon Screening Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Colon Screening Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 U.S. Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 Canada Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 9 Mexico Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 10 Europe Colon Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 11 Europe Colon Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 12 UK. Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 13 Germany Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 France Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 15 Italy Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 16 Spain Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 Denmark Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 18 Sweden Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 19 Norway Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Colon Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 22 Japan Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 23 China Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 24 India Colon Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 25 Australia Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 26 Thailand Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 South Korea Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 28 Latin America Colon Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 29 Latin America Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 30 Brazil Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 31 Argentina Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Colon Screening Market, by Country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 34 South Africa Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 UAE Colon Screening Market, by Type, 2018 - 2030 (USD Million)
  • Table 37 Kuwait Colon Screening Market, by Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Colon Screening market: outlook
  • Fig. 9 Colon Screening competitive insights
  • Fig. 10 Ancillary market outlook
  • Fig. 11 Colon Screening market driver impact
  • Fig. 12 Colon Screening market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 Colon Screening market: Type movement analysis
  • Fig. 16 Colon Screening market: Type outlook and key takeaways
  • Fig. 17 Test market estimates and forecast, 2018 - 2030
  • Fig. 18 Colonoscopy market estimates and forecast, 2018 - 2030
  • Fig. 19 Capsule Endoscopy market estimates and forecast, 2018 - 2030
  • Fig. 20 Imaging Tests market estimates and forecast, 2018 - 2030
  • Fig. 21 Virtual Colonoscopy market estimates and forecast, 2018 - 2030
  • Fig. 22 Magnetic resonance colonography (MRC) market estimates and forecast, 2018 - 2030
  • Fig. 23 Others market estimates and forecast, 2018 - 2030
  • Fig. 24 By Test, Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 25 By Test, Outpatient Facilities market estimates and forecasts,2018 - 2030
  • Fig. 26 Product market estimates and forecast, 2018 - 2030
  • Fig. 27 Colonoscopes market estimates and forecast, 2018 - 2030
  • Fig. 28 Sigmoidoscopes market estimates and forecast, 2018 - 2030
  • Fig. 29 CT Scanners market estimates and forecast, 2018 - 2030
  • Fig. 30 Magnetic Resonance Imaging (MRI) market estimates and forecast, 2018 - 2030
  • Fig. 31 By Product, Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 32 By Product, Outpatient Facilities market estimates and forecasts,2018 - 2030
  • Fig. 33 Global colon screening market: Regional movement analysis
  • Fig. 34 Global colon screening market: Regional outlook and key takeaways
  • Fig. 35 North America colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 U.S. colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 Canada colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Mexico colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Europe colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 UK colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Germany colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Spain colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 France colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Italy colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Norway colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Denmark colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Sweden colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Japan colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 China colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 India colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Australia colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 South Korea colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Thailand colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Brazil colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Argentina colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 MEA colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Africa colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Saudi Arabia colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 UAE colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Kuwait colon screening market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key company categorization
  • Fig. 87 Heat map analysis 2024
目次
Product Code: GVR-4-68040-523-1

Colon Screening Market Growth & Trends:

The global colon screening market size is expected to reach USD 22.21 billion by 2030, registering a CAGR of 4.39% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of colorectal cancer, increasing government initiatives to encourage cancer screening, and ongoing technological advancements in the market are major factors driving the market growth. According to CDC data published in June 2024, the prevalence of IBD in the U.S. is estimated between 2.4 and 3.1 million. Similarly, the worldwide prevalence of ulcerative colitis was expected to be 5 million in 2023.

The development of technologically advanced products in colon screening has significantly contributed to the market's growth. These innovations have enhanced diagnostic accuracy, improved patient comfort, minimized risks associated with traditional procedures, and enabled earlier detection of colon-related diseases, including cancer and polyps. For instance, in May 2024, FUJIFILM launched two innovative endoscopic imaging technologies: CAD EYE and SCALE EYE. CAD EYE is an AI-powered system designed to enhance the detection of colonic mucosal lesions such as polyps and adenomas during colonoscopy.

In addition, the increasing efforts by private and public players worldwide to increase awareness and accessibility of colon screening have further driven the market across different regions. For instance, in November 2024, Guam Regional Medical City introduced an advanced capsule endoscopy service funded by a grant from the USDA Rural Development Program. This innovative, minimally invasive diagnostic solution represents a significant advancement in gastrointestinal healthcare for Guam and the surrounding region, enhancing medical technology while prioritizing patient comfort. Such developments increase access to advanced diagnosis services, thus driving market growth.

Moreover, the widespread adoption of routine screening programs has an effective role in detecting cancers & precancerous polyps. In addition, advancements in colonoscopy technology, including AI-assisted detection, have improved diagnostic efficiency and patient outcomes. For instance, in December 2023, Medtronic expanded its artificial intelligence collaboration with Cosmo Pharmaceuticals, the developer of plug-in software designed to detect health issues during endoscopic examinations automatically.

Key players in the market are engaged in technological advancements, new product launches, and partnerships & collaborations to gain a higher market share. For instance, in February 2022, Medtronic collaborated with the American Society for Gastrointestinal Endoscopy (ASGE) to offer AI-powered colonoscopy technology for colorectal cancer screening in underserved communities of the U.S.

Colon Screening Market Report Highlights:

  • Based on type, the test segment held the largest revenue share in the market in 2024. Rising demand for simple and non-invasive screening procedures is propelling the segment growth.
  • Based on end use, the hospital segment held the largest revenue share in the market in 2024, owing to the growing number of hospital admissions due to colon cancer and the rise in the adoption of cancer screening.
  • North America dominated the global market with a revenue share of 51.3% in 2024 due to the presence of a large number of major market players and the high adoption of advanced technologies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Product outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Colon Screening Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of colorectal diseases
      • 3.2.1.2. Favorable government initiatives and reimbursement policies
      • 3.2.1.3. Introduction of technologically advanced products
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations
  • 3.3. Colon Screening: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic Landscape
      • 3.3.2.3. Social Landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Environmental Landscape
  • 3.4. Colon Screening Market Number of Procedures, 2018 - 2024
  • 3.5. Colon Screening Market Pricing Analysis by Product

Chapter 4. Colon Screening Market Segment Analysis, By Type, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Colon Screening Market, by Type, 2018 to 2030
  • 4.5. Test
    • 4.5.1. Test Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Colonoscopy
      • 4.5.2.1. Colonoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Capsule Endoscopy
      • 4.5.3.1. Capsule Endoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Imaging Tests
      • 4.5.4.1. Imaging Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.4.2. Virtual Colonoscopy
        • 4.5.4.2.1. Virtual Colonoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.4.3. Magnetic resonance colonography (MRC)
        • 4.5.4.3.1. Magnetic resonance colonography (MRC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. End Use, By Test
      • 4.5.6.1. Hospitals
        • 4.5.6.1.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.6.2. Outpatient Facilities
        • 4.5.6.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Product
    • 4.6.1. Product Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Colonoscopes
      • 4.6.2.1. Colonoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Sigmoidoscopes
      • 4.6.3.1. Sigmoidoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. CT Scanners
      • 4.6.4.1. CT Scanners Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Magnetic Resonance Imaging (MRI)
      • 4.6.5.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. End Use, By Product
      • 4.6.6.1. Hospitals
        • 4.6.6.1.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.6.6.2. Outpatient Facilities
        • 4.6.6.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Colon Screening Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Regional Market Snapshot
  • 5.4. Colon Screening Market Share by Region, 2024 & 2030:
  • 5.5. North America
    • 5.5.1. North America colon screening market, 2018 - 2030 (USD Million)
    • 5.5.2. U.S.
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. U.S. colon screening market, 2018 - 2030 (USD Million)
    • 5.5.3. Canada
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. Canada colon screening market, 2018 - 2030 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Mexico colon screening market, 2018 - 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. Europe colon screening market, 2018 - 2030 (USD Million)
    • 5.6.2. UK
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. UK colon screening market, 2018 - 2030 (USD Million)
    • 5.6.3. Germany
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. Germany colon screening market, 2018 - 2030 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. France colon screening market, 2018 - 2030 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key country dynamics
      • 5.6.5.2. Regulatory framework
      • 5.6.5.3. Competitive scenario
      • 5.6.5.4. Italy colon screening market, 2018 - 2030 (USD Million)
    • 5.6.6. Spain
      • 5.6.6.1. Key country dynamics
      • 5.6.6.2. Regulatory framework
      • 5.6.6.3. Competitive scenario
      • 5.6.6.4. Spain colon screening market, 2018 - 2030 (USD Million)
    • 5.6.7. Norway
      • 5.6.7.1. Key country dynamics
      • 5.6.7.2. Regulatory framework
      • 5.6.7.3. Competitive scenario
      • 5.6.7.4. Norway colon screening market, 2018 - 2030 (USD Million)
    • 5.6.8. Sweden
      • 5.6.8.1. Key country dynamics
      • 5.6.8.2. Regulatory framework
      • 5.6.8.3. Competitive scenario
      • 5.6.8.4. Sweden colon screening market, 2018 - 2030 (USD Million)
    • 5.6.9. Denmark
      • 5.6.9.1. Key country dynamics
      • 5.6.9.2. Regulatory framework
      • 5.6.9.3. Competitive scenario
      • 5.6.9.4. Denmark colon screening market, 2018 - 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. Japan colon screening market, 2018 - 2030 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. China colon screening market, 2018 - 2030 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. India colon screening market, 2018 - 2030 (USD Million)
    • 5.7.4. Australia
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Australia colon screening market, 2018 - 2030 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. South Korea colon screening market, 2018 - 2030 (USD Million)
    • 5.7.6. Thailand
      • 5.7.6.1. Key country dynamics
      • 5.7.6.2. Regulatory framework
      • 5.7.6.3. Competitive scenario
      • 5.7.6.4. Thailand colon screening market, 2018 - 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Regulatory framework
      • 5.8.1.3. Competitive scenario
      • 5.8.1.4. Brazil colon screening market, 2018 - 2030 (USD Million)
    • 5.8.2. Argentina
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Regulatory framework
      • 5.8.2.3. Competitive scenario
      • 5.8.2.4. Argentina colon screening market, 2018 - 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. South Africa
      • 5.9.1.1. Key country dynamics
      • 5.9.1.2. Regulatory framework
      • 5.9.1.3. Competitive scenario
      • 5.9.1.4. South Africa colon screening market, 2018 - 2030 (USD Million)
    • 5.9.2. Saudi Arabia
      • 5.9.2.1. Key country dynamics
      • 5.9.2.2. Regulatory framework
      • 5.9.2.3. Competitive scenario
      • 5.9.2.4. Saudi Arabia colon screening market, 2018 - 2030 (USD Million)
    • 5.9.3. UAE
      • 5.9.3.1. Key country dynamics
      • 5.9.3.2. Regulatory framework
      • 5.9.3.3. Competitive scenario
      • 5.9.3.4. UAE colon screening market, 2018 - 2030 (USD Million)
    • 5.9.4. Kuwait
      • 5.9.4.1. Key country dynamics
      • 5.9.4.2. Regulatory framework
      • 5.9.4.3. Competitive scenario
      • 5.9.4.4. Kuwait colon screening market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Profiles
    • 6.3.1. Olympus Corporation
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Platform benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. PENTAX Medical (Hoya Corporation)
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Platform benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. FUJIFILM Holdings Corporation
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Platform benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Medtronic
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Platform benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Ambu A/S
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Platform benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Baxter (Hillrom & Welch Allyn)
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Platform benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. EndoFresh (Daichuan medical)
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Platform benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Bracco
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Platform benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Varay Laborix
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Platform benchmarking
      • 6.3.9.4. Strategic initiatives